In analyzing the forecasted mortality rate due to malignant neoplasms in Brazil from 2024 to 2028, data shows a steady year-on-year increase in female deaths per hundred thousand women, starting at 105.2 in 2024 and rising to 109.9 by 2028. Given the absence of historical data for 2023, we focus on the upcoming linear growth trend, indicating a significant public health concern.
The average annual increase (CAGR) over this period is anticipated around this rising trend. This ongoing rise in mortality rates underscores the urgency on healthcare systems to prioritize cancer prevention and treatment strategies.
Future trends to watch for include technological advancements and policy changes in cancer diagnostics and treatment, impacts of lifestyle factors, and potential improvements in healthcare accessibility that could mitigate these mortality rates.
